Recursion Pharmaceuticals
RXRX
#5083
Rank
โ‚น164.58 B
Marketcap
โ‚น264.02
Share price
3.86%
Change (1 day)
-28.33%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2026 (TTM): -โ‚น44.89 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are โ‚น67.01 Million. In 2025 the company made an earning of -โ‚น60.11 Billion a decrease over its 2024 earnings that were of -โ‚น43.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น44.89 Billion-25.32%
2025 -โ‚น60.11 Billion38.83%
2024 -โ‚น43.3 Billion39.51%
2023 -โ‚น31.04 Billion38.68%
2022 -โ‚น22.38 Billion30.46%
2021 -โ‚น17.16 Billion114.28%
2020 -โ‚น8.01 Billion